Performance of Previously Identified Predictors of >=15% Body Weight Reduction with Tirzepatide in Participants with Type 2 Diabetes in SURMOUNT-2

被引：0
|
作者：
Lingvay, Ildiko
Malecki, Maciej
Benabbad, Imane
Falcon, Beverly
Lee, Clare
Wang, Hui
Dunn, Julia P.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-815-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
815-P
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Tirzepatide shows beneficial effects on body fat distribution pattern in people with type 2 diabetes
    Linge, J.
    Cariou, B.
    Neeland, I. J.
    Leinhard, O. Dahlqvist
    Petersson, M.
    Fernandez, L.
    Bray, R.
    Rodriguez, A.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S286 - S287
  • [42] Type of Vegetarian Diet, Body Weight, and Prevalence of Type 2 Diabetes
    Tonstad, Serena
    Butler, Terry
    Yan, Ru
    Fraser, Gary E.
    DIABETES CARE, 2009, 32 (05) : 791 - 796
  • [43] Predictors of achieving and sustaining glycaemic control and weight loss with tirzepatide in individuals with type 2 diabetes and increased cardiovascular risk (SURPASS-4)
    Kahn, S. E.
    Del Prato, S.
    Pavo, I.
    Franco, D. R.
    Zheng, J.
    Nicolay, C.
    Hemmingway, A.
    Wiese, R. J.
    Pearson, E. R.
    DIABETOLOGIA, 2024, 67 : S362 - S362
  • [44] Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
    Michael A. Nauck
    David A. D‘Alessio
    Cardiovascular Diabetology, 21
  • [45] Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
    Nauck, Michael A.
    D'Alessio, David A.
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [46] Impact of Newer Medications for Type 2 Diabetes on Body Weight
    Pedersen S.D.
    Current Obesity Reports, 2013, 2 (2) : 134 - 141
  • [47] Aggressive weight reduction treatment in the management of Type 2 diabetes
    Scheen, AJ
    DIABETES & METABOLISM, 1998, 24 (02): : 116 - 123
  • [48] The role of education and weight reduction in control of type 2 diabetes
    Nikousokhan, AK
    Rajab, A
    DIABETES, 2002, 51 : A528 - A528
  • [49] Weight Reduction Strategies for Patients with Type-2-Diabetes
    Blueher, M.
    DIABETOLOGE, 2017, 13 (02): : 123 - 136
  • [50] Comment on "Obesity/Type 2 Diabetes: GLP-1 Agonist Tirzepatide Promotes Weight Loss"
    Blueher, Matthias
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 415 - 416
12345